IgG antibodies in patients with pemphigus vulgaris before and after diagnosing with immunofluorescence.

Pemphigus is defined as a group of chronic self-immune vesicular diseases histologically recognized by inter-epidermic vesicles resulting from acantholysis. The aim of this study was to evaluate the precipitant and circulative IgG antibodies in patients with pemphigus vulgaris before and after treating with immunofluorescence. Sixty-two patients (34 females and 28 males) with clinically and pathologically confirmed P.V. were studied prospectively over a one year period of time during which direct and indirect immunofluorescent tests were performed before and after treatment. They had mild or moderate forms of disease. All patients received prednisolon 1-2 mg/kg/day and Azathioprine 2-3 mg/kg/day or methylpredisolon (1 g day(-1) for 4 days) and cyclophosphamide (500 mg/first day) pulse therapy due to general condition. Thirty- four females and 28 males enrolled, the mean age were 39.5 years (SD = 12.7). Before treatment, 10 and 52 cases were positive for skin depositing + or ++) and circulatory IgG (1/20 -1/60), respectively. Two to 3 month later, 37 were IgG positive with titers 1/20 to 1/160. The correlation between circulatory IgG before and after treatment was weakly positive (p = 0.05, r = 0.415). In the present study, treatment methods used for patients suffering from pemphigus vulgaris were not successful in significantly decreasing the circulative autoantibodies levels.

[1]  T. Funakoshi,et al.  Enrichment of total serum IgG4 in patients with pemphigus , 2012, The British journal of dermatology.

[2]  A. Marconi,et al.  Apoptotic pathways in the pathogenesis of pemphigus: targets for new therapies. , 2012, Current pharmaceutical biotechnology.

[3]  B. Qaqish,et al.  IgG Autoantibody Response Against Keratinocyte Cadherins in Endemic Pemphigus Foliaceus (Fogo Selvagem) , 2012, The Journal of investigative dermatology.

[4]  T. Hashimoto,et al.  Atypical pemphigus with exclusively anti-desmocollin 3-specific IgG antibodies. , 2012, European journal of dermatology : EJD.

[5]  M. Goldust,et al.  Treatment of scabies: Comparison of permethrin 5% versus ivermectin , 2012, The Journal of dermatology.

[6]  M. Hertl,et al.  Differential IgG recognition of desmoglein 3 by paraneoplastic pemphigus and pemphigus vulgaris sera. , 2012, The Journal of investigative dermatology.

[7]  H. Koga,et al.  Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules. , 2012, The Journal of investigative dermatology.

[8]  R. Eming,et al.  Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult‐to‐treat pemphigus vulgaris , 2012, The British journal of dermatology.

[9]  M. Komine,et al.  A case of IgG/IgA pemphigus presenting malar rash-like erythema. , 2012, Acta dermato-venereologica.

[10]  D. Zillikens,et al.  Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides. , 2012, Journal of dermatological science.

[11]  T. Olivry,et al.  Metaflumizone-amitraz (Promeris)-associated pustular acantholytic dermatitis in 22 dogs: evidence suggests contact drug-triggered pemphigus foliaceus. , 2011, Veterinary dermatology.

[12]  M. Mokni,et al.  Spectrum of autoantibodies other than anti‐desmoglein in pemphigus patients , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[13]  M. Goldust,et al.  Treatment of solar lentigines with trichloroacetic acid 40% vs. cryotherapy. , 2011, European journal of dermatology : EJD.

[14]  T. Nishikawa,et al.  Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris. , 2011, International immunology.

[15]  Y. Hanakawa,et al.  Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3. , 2011, The Journal of investigative dermatology.

[16]  L. Peltonen,et al.  Aire-dependent thymic expression of desmoglein 3, the autoantigen in pemphigus vulgaris, and its role in T-cell tolerance. , 2011, The Journal of investigative dermatology.

[17]  M. Lanza,et al.  Deregulation of PERK in the autoimmune disease pemphigus vulgaris occurs via IgG‐independent mechanisms , 2011, The British journal of dermatology.

[18]  T. Hashimoto,et al.  IgG/IgA pemphigus with IgA and IgG antidesmoglein 1 antibodies detected by enzyme‐linked immunosorbent assay: presentation of two cases , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[19]  T. Hashimoto,et al.  Paraneoplastic pemphigus herpetiformis with IgG antibodies to desmoglein 3 and without mucosal lesions. , 2011, Archives of dermatology.

[20]  Y. Aoyama,et al.  Binding of pemphigus vulgaris IgG to antigens in desmosome core domains excludes immune complexes rather than directly splitting desmosomes , 2010, The British journal of dermatology.